Hypofractionated whole breast radiotherapy: current perspectives
Authors:
Open Access
- 1 October 2015
- journal article
- review article
- Published by Taylor & Francis in Breast Cancer: Targets and Therapy
- Vol. ume 7, 363-370
Abstract
Adjuvant radiotherapy (RT) is an important part of breast cancer management but the dose and fractionation schedules used are variable. A total of 50 Gy in 25 daily fractions delivered over 5 weeks is often considered the "standard" adjuvant RT prescription. Hypofractionated regimes such as 42.5 Gy in 16 daily fractions or 40 Gy in 15 daily fractions following breast-conserving surgery have proven to be equally effective and achieve similar or better cosmetic and normal tissue outcomes for both invasive and in situ diseases and when treating the regional nodes. Hypofractionation is more convenient for patients and less costly. However, certain patients at higher risk of RT late effects may benefit from a less intense, even more extended fractionation schedule. This review describes the indications for whole breast hypofractionated adjuvant RT for patients with breast cancer following breast-conserving surgery and proposes that hypofractionation should be the new "standard" for adjuvant breast cancer RT.Keywords
This publication has 58 references indexed in Scilit:
- Long-term Cardiac Mortality After Hypofractionated Radiation Therapy in Breast CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2013
- Health-related quality of life in survivors of stage I-II breast cancer: randomized trial of post-operative conventional radiotherapy and hypofractionated tomotherapyBMC Cancer, 2012
- Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trialsThe Lancet, 2011
- Fractionation for Whole Breast Irradiation: An American Society for Radiation Oncology (ASTRO) Evidence-Based GuidelineInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2011
- Effect of radiotherapy boost and hypofractionation on outcomes in ductal carcinoma in situCancer, 2010
- Long-Term Results of Hypofractionated Radiation Therapy for Breast CancerNew England Journal of Medicine, 2010
- Locoregional Radiation Therapy in Patients With High-Risk Breast Cancer Receiving Adjuvant Chemotherapy: 20-Year Results of the British Columbia Randomized TrialJNCI: Journal of the National Cancer Institute, 2005
- The Role of Biologically Effective Dose (BED) in Clinical OncologyClinical Oncology, 2001
- Five-Year Results of a Randomized Clinical Trial Comparing Total Mastectomy and Segmental Mastectomy with or without Radiation in the Treatment of Breast CancerNew England Journal of Medicine, 1985
- Comparing Radical Mastectomy with Quadrantectomy, Axillary Dissection, and Radiotherapy in Patients with Small Cancers of the BreastNew England Journal of Medicine, 1981